Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Poupak Fallahi

Showing results (261-270 of 270) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 270 results.
Journal of Clinical Medicine|September 28, 2021
Expression and Clinical Utility of Transcription Factors Involved in Epithelial-Mesenchymal Transition during Thyroid Cancer ProgressionEnke Baldini, Chiara Tuccilli, Daniele Pironi, et al.
Clinical Rheumatology|August 28, 2020
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients seriesClodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, et al.
Journal of Clinical Immunology|February 16, 2023
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and ImmunogenicityLaura Gragnani, Marcella Visentini, Serena Lorini, et al.
Journal of Autoimmunity|July 16, 2022
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseasesClodoveo Ferri, Laura Gragnani, Vincenzo Raimondo, et al.
Journal of Autoimmunity|November 15, 2021
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroupsClodoveo Ferri, Francesco Ursini, Laura Gragnani, et al.
The Lancet. Rheumatology|February 1, 2021
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey studyClodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 2025
Prospective Validation of ATA Risk Score for Papillary Thyroid Microcarcinoma: An ITCO Real-World StudySimone De Leo, Giulia Brigante, Silvia D'Elia, et al.
Journal of Translational Autoimmunity|October 19, 2023
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phaseClodoveo Ferri, Vincenzo Raimondo, Dilia Giuggioli, et al.
Current Pharmaceutical Design|September 3, 2021
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing TreatmentsClodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, et al.
Current Pharmaceutical Design|June 21, 2022
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing TherapiesClodoveo Ferri, Vincenzo Raimondo, Laura Gragnani, et al.
Pageof 27

Showing results (261-270 of 270) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 270 results.
Journal of Clinical Medicine|September 28, 2021
Expression and Clinical Utility of Transcription Factors Involved in Epithelial-Mesenchymal Transition during Thyroid Cancer ProgressionEnke Baldini, Chiara Tuccilli, Daniele Pironi, et al.
Clinical Rheumatology|August 28, 2020
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients seriesClodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, et al.
Journal of Clinical Immunology|February 16, 2023
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and ImmunogenicityLaura Gragnani, Marcella Visentini, Serena Lorini, et al.
Journal of Autoimmunity|July 16, 2022
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseasesClodoveo Ferri, Laura Gragnani, Vincenzo Raimondo, et al.
Journal of Autoimmunity|November 15, 2021
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroupsClodoveo Ferri, Francesco Ursini, Laura Gragnani, et al.
The Lancet. Rheumatology|February 1, 2021
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey studyClodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 2025
Prospective Validation of ATA Risk Score for Papillary Thyroid Microcarcinoma: An ITCO Real-World StudySimone De Leo, Giulia Brigante, Silvia D'Elia, et al.
Journal of Translational Autoimmunity|October 19, 2023
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phaseClodoveo Ferri, Vincenzo Raimondo, Dilia Giuggioli, et al.
Current Pharmaceutical Design|September 3, 2021
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing TreatmentsClodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, et al.
Current Pharmaceutical Design|June 21, 2022
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing TherapiesClodoveo Ferri, Vincenzo Raimondo, Laura Gragnani, et al.
Pageof 27